China's Sinopharm begins late stage trial of COVID-19 vaccine in UAE

  • 📰 Reuters
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Chinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Abu Dhabi using up to 15,000 volunteers, the government in the capital of the United Arab Emirates said on Thursday.

FILE PHOTO: The company logo of Sinopharm Group Co Ltd is displayed at a news conference on the company's annual results in Hong Kong, China March 29, 2016. REUTERS/Bobby Yip/File Photo

No COVID-19 vaccine has yet been approved for commercial use. According to a WHO summary of the state of vaccine development for COVID-19, there are 23 potential vaccines in human trials, with three of them in or starting large-scale late stage, or Phase III, trials to test efficacy. Sinopharm chose the United Arab Emirates because around 200 different nationalities reside there and it has a focus on medical research and fighting the pandemic, Koshy said.

China has been looking overseas to trial potential vaccines because of a lack of new patients at home. China’s Sinovac Biotech is conducting Phase III trials of a vaccine in Brazil.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

I wouldn’t be trusting any vaccine made by a Chinese company 🙅🏼‍♂️

Chinese vaccines target Asian genes, so research in the U.S. needs to be accelerated!

Don’t trust anything China says or does. They perpetrated this virus on the world and must pay

PREVENTION IS BETTER THAN CURE, AND MUCH CHEAPER TOO ! Share this with someone you love, for their sake

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Early-stage trial data on AstraZeneca COVID-19 vaccine due July 20 - LancetThe Lancet medical journal said on Wednesday it will publish keenly-awaited phase 1 clinical trial data on a potential COVID-19 vaccine being developed by Astrazeneca and Oxford University on Monday. Oh shit. AstraZeneca will price-gouge everyone! should I buy or sell ?
Source: Reuters - 🏆 2. / 97 Read more »

Moderna expects to start late-stage COVID-19 vaccine trial on July 27Moderna Inc said on Tuesday it plans to start a late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov. At this point in the constant pump train, would they even tell us about severe side effects? When Trump said by the end of the year everybody laughed at him stop hating and start hoping Why does it look like Tesco own brand?
Source: Reuters - 🏆 2. / 97 Read more »

Early-stage trial data on AstraZeneca COVID-19 vaccine due Monday - LancetEarly-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
Source: Reuters - 🏆 2. / 97 Read more »

Potential COVID-19 vaccine shows promise in early trial'It is good news that it's not bad news,' infectious disease expert Dr. Michael Osterholm says about promising results from Moderna's first COVID-19 vaccine trial. 'But remember, we're in the first 100 yards of a marathon.'
Source: MSNBC - 🏆 469. / 51 Read more »

COVID-19 vaccine: Early Oxford trial data to be published next weekThe World Health Organization's chief scientist said in June that the vaccine was probably the most advanced in terms of development.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »